EG Bio Expands Its Portfolio with Citrus Bottle from Genèse Labs France

In April 2024, EG Bio Co., Ltd. expanded its international aesthetic portfolio with the introduction of Citrus Bottle, a product developed by Genèse Labs France, into its global distribution lineup.

Citrus Bottle was selected to complement EG Bio’s existing aesthetic offerings, strengthening the company’s presence in the fat-dissolving and body-contouring category. Through its established B2B distribution network, EG Bio supports the structured market introduction and international distribution of Citrus Bottle in cooperation with regional partners.

The addition of Citrus Bottle reflects EG Bio’s ongoing strategy of expanding its portfolio through carefully selected products from internationally positioned brands. By combining Genèse Labs France’s product development expertise with EG Bio’s global distribution capabilities, the cooperation supports clear brand positioning, reliable supply, and sustainable market development.

With Citrus Bottle joining its portfolio, EG Bio continues to reinforce its role as a strategic distribution partner for aesthetic brands seeking structured access to international markets.

About EG Bio

EG Bio Co., Ltd. is a global B2B supplier and distribution partner specializing in professional aesthetic products. The company works with selected international brands and manufacturers to support structured global distribution, market development, and long-term partnerships. EG Bio focuses on exclusive distribution models, portfolio development, and international market access, supporting distributors and professional partners across multiple regions through a transparent and compliance-oriented approach.

About Genèse Labs France

Genèse Labs France is a France-based aesthetic company focused on the development and management of professional aesthetic and dermocosmetic product portfolios. The company works with selected manufacturing and distribution partners to support structured international expansion, emphasizing regulatory alignment, clear brand positioning, and long-term market development.